Papers
16
Total Citations
393
H-Index
11
About
Adam Luginbuhl is a leading head and neck surgeon whose work has fundamentally shaped the modern practice of transoral robotic surgery (TORS). His research centers on three critical areas: expanding the surgical applications of TORS, optimizing patient outcomes through evidence-based perioperative care, and understanding the nuanced interplay between patient factors and treatment success. Luginbuhl’s major contributions include pioneering the use of TORS for parapharyngeal space tumors, demonstrating its safety and efficacy in a seminal 2016 case series (77 citations), and establishing the feasibility of new robotic programs in a post-FDA approval setting (28 citations). He has also been instrumental in developing evidence-based guidelines for postoperative pain management, directly addressing the opioid crisis through a multiphasic study (48 citations). His work on intraoperative neuromonitoring to prevent brachial plexus injury during transaxillary thyroidectomy (42 citations) and his analyses of smoking’s impact on HPV-positive oropharyngeal cancer outcomes (38 citations) have provided crucial insights for risk stratification and surgical planning. Through these contributions, Luginbuhl has not only advanced surgical technique but also improved the safety, quality, and personalization of care for patients with head and neck cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Unplanned readmission following transoral robotic surgery34 citations · 2017
- 6Early Adoption of Transoral Robotic Surgical Program28 citations · 2012
- 7
- 8
- 9
- 10